Admetsys

Join Admetsys at 14:30pm GMT on 2nd December 2020 online at GIANT 2020 @gianthealthevnt to learn more about Admetsys' PrecisionOne™ Automated Glycemic Control and Continuous Diagnostics System for Hospital and Surgical Care. prnewswire.com/news-releases/…

#TechTop50Honoree Congrats to .@admetsys for their PrecisionOne system that functions as a metabolic autopilot, providing automated gluclose regulation and real-time blood chemistry analysis for diabetes patients👏 #Innovation

Admetsys is honored to join @1up_health @athenahealth @AGmobilerobots @BIOMODEX @CardioLogs @Indigoag @NexthinkNews @Voatz and @Wevoconversion as a @MassTLC outstanding tech company for innovation in 2020 at the #TechTop50 digital experience. masstlc.org/masstlc-announ…

Admetsys is honored to join @1up_health @athenahealth .@AGmobilerobots @BIOMODEX @CardioLogs @Indigoag @NexthinkNews @Voatz and @Wevoconversion as an @MassTLC outstanding tech company for innovation in 2020 at the #TechTop50 digital experience.

Congrats to @admetsys for being recognized as a #TechTop50 for their innovation in 2020! Well done! 🎉

Admetsys is honored to be nominated to the @MassTLC Tech Top 50 program for the recent CE Mark approval of the novel PrecisionOne™ Automated Glycemic Control and Continuous Diagnostics System. #ThankYou finance.yahoo.com/news/admetsys-…

Admetsys Secures CE Mark Approval for PrecisionOne™ Automated Glycemic Control and Continuous Diagnostics System 👏👏👏👏 prnewswire.com/news-releases/…

Poorly-controlled glucoses in hospitalized #COVID19 patients increases death rates significantly. "These findings provide clinical evidence correlating improved glycemic control with better outcomes in patients with COVID-19 and pre-existing T2D." pubmed.ncbi.nlm.nih.gov/32369736/

Admetsys is proud to announce that we have received a CE mark in Europe. Thank you to all of our advocates, advisors and investors for helping us change the landscape of hospital care. @T1DExchange @dreamit @BaptistHealthAR @ArkBlueCross @ZellLurie

In Conversation: Admetsys CEO Jeff Valk synthetic.com/in-conversatio… @admetsys

All the companies did amazing last night. Thank you to everyone who help made this possible. The Finale Results on the war on COVID Competition 1 st place Lincoln advantage technologies 2nd place @admetsys And a tie for crowd favorite @PhenoMxInc and @elemenohealth

Come watch the companies that are changing the healthcare landscape and addressing #COVID19 head on! #WarOnCovid @helpsyhealth @f2fhealth @elemenohealth @EmanateWireless @PhenoMxInc @healthmodeHQ @admetsys, and rivertown bioscience. Plus 2 wildcards! bit.ly/3csj17M

@elonmusk When is the CyberJeep coming? We need something to look forward to as we work through this rough patch for everyone.

The Health Start-Up Challenge returns! Watch Joe Buffone @annexushealth, Kevin Bambury @ONCOassist, @jordanlmills @mirrorme3d, Jeff Valk @admetsys & @patanq @portalcambridge deliver their pitches. YOU decide who wins, vote here: bit.ly/2xlG0To #efpvirtual

Watch @Admetsys present on creating value for patients and healthcare at #efpPhilly @eyeforpharma Philadelphia Virtual, the largest commercial pharma conference, on April 14th at 5 PM ET. Register at eyeforpharma.com/philadelphia/c… #ArtificialPancreas #T1D

Thank you to @MedStartr @Health2eu #Health20NYC for allowing us to join the #WarOnCOVID Challenge during these unique times. We look forward to working with you and other innovators as we jointly work towards mitigating #COVID19 and supporting medical staff and patients.

We analyzed @CDCgov prevalence of #ChronicDisease and #COVID19 data: those w/ #diabetes infected w/ #COVID19 are ~7 times as likely to need the ICU vs. those w/o diabetes. #NCDs prevention saves health systems & lives: @WHO @DrEricDing @andreafeigl1 @sandrogalea @ncdalliance

See @Admetsys and other great innovators present online tomorrow as part of the @MedStartr @Health2eu #Health20NYC #WarOnCOVID Challenge as we work towards mitigating #COVID19 through information-driven scalable diagnostics and automated care. Join via meetup.com/health20nyc/ev…

The MBRIF has two distinct offerings for startups: 1. Accelerator 2. Government backed guarantees. Admetsys, a Boston based medical startup, was a member of our accelerator’s first cohort. This facilitated their growth in the UAE & other countries outside of their home turf. 👇

Their accelerator journey enabled them to kick-off qualification discussions for the Guarantee Scheme, which provides financial solutions for innovative companies. Get in touch and learn more here: mbrif.ae #MBRIF